Canopus Biopharma, Inc.

OTC: CBIA · Healthcare · Medical - Pharmaceuticals

PublicHQ Las Vegas, NV · ClarkCIK 0001404356Reports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 57

v0.1 · 5/100 weight · pillars only

↑ listing tenure, workforce scale · ↓ Piotroski F, Altman-Z

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

as of 2026-08-27

Market cap

$455.1k

as of 2026-08-27

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Canopus Biopharma, Inc.’s financial profile?

Canopus Biopharma, Inc. has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

CERo Therapeutics Holdings, Inc.——Solanbridge Group, Inc.——CaliPharms, Inc.——OJsys, Inc.——PPJ Healthcare Enterprises, Inc.——Mosaic ImmunoEngineering Inc.——

Neighbors

Clark →

Las Vegas Sands Corp.$13.0B80B+MGM Resorts International$17.5B68B Wynn Resorts, Limited$7.1B65B Bitmine Immersion Technologies, Inc.$6.1M46D MP Materials Corp.$224.4M49D Southwest Gas Holdings, Inc.$5.4B55C

Key facts

CEOPatrick T. Prendergast

SectorHealthcare

IndustryMedical - Pharmaceuticals

HeadquartersLas Vegas, NV

ExchangeOTC: CBIA

Employees72

IPO date1999-12-31

Latest filings

No filings loaded.

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.